- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Hexaminolevulinate.
Displaying page 1 of 1.
EudraCT Number: 2010-023903-91 | Sponsor Protocol Number: PCCE203/10 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Photocure ASA | |||||||||||||
Full Title: A randomized phase II dose-finding study of hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with low/moderate-grade cervical intraepithelial neoplasia (CIN1 or 2). | |||||||||||||
Medical condition: Patients with low/moderate-grade cervical intraepithelial neoplasia (CIN1 or 2). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) SK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004269-34 | Sponsor Protocol Number: PCB202/11 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Photocure ASA | |||||||||||||
Full Title: An open, prospective, within-patient, controlled, multi-center phase IIa study of Hexvix flexible fluorescence cystoscopy and white light flexible cystoscopy in the detection of bladder cancer afte... | |||||||||||||
Medical condition: The patients should be indicated for a transurethral resection of the bladder (TURB) based on an outpatient cystoscopy and fulfil the following inclusion criteria: • Patients with multiple bladder... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001711-38 | Sponsor Protocol Number: PC CO 201/08 | Start Date*: 2008-12-16 |
Sponsor Name:Photocure ASA | ||
Full Title: An open dose-finding study of oral applied hexaminolevulinate (HAL) imaging in patients with suspicion or high risk of dysplasia or neoplasia in the colon | ||
Medical condition: Patients with suspicion or high risk of neoplasia in the colon | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-000559-15 | Sponsor Protocol Number: FB2012 | Start Date*: 2012-09-14 |
Sponsor Name:FinnBladder | ||
Full Title: TREATMENT OF Ta BLADDER CANCER WITH HIGH RISK OF RECURRENCE – FLUORESCENCE CYSTOSCOPY WITH OPTIMIZED ADJUVANT MITOMYCIN-C | ||
Medical condition: bladder cancer (non-invasive Ta urothelial bladder cancer) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004604-31 | Sponsor Protocol Number: PCCE201/08 | Start Date*: 2008-10-28 | |||||||||||
Sponsor Name:Photocure ASA | |||||||||||||
Full Title: A randomized phase II dose-finding study of hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with low-grade cervical intraepithelial neoplasia. | |||||||||||||
Medical condition: Low grade cervical intraepithelial neoplasia (CIN) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002259-15 | Sponsor Protocol Number: PCB305/04 | Start Date*: 2005-01-24 | |||||||||||
Sponsor Name:Photocure ASA | |||||||||||||
Full Title: A RANDOMIZED, COMPARATIVE,CONTROLLED PHASE III, MULTICENTER STUDY OF HEXVIX FLUORESCENCE CYSTOSCOPY ANDWHITE LIGHT CYSTOSCOPY IN THE DETECTION OF PAPILLARY BLADDER CANCER AND THE EARLYRECURRENCE RA... | |||||||||||||
Medical condition: Malignant neoplasm of bladder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001342-19 | Sponsor Protocol Number: YHGT-CEV-R1 | Start Date*: 2020-11-13 | |||||||||||
Sponsor Name:Asieris MediTech Co., Ltd. | |||||||||||||
Full Title: A double blind, prospective, randomized, placebo controlled, multi-center phase 3 study to evaluate efficacy and safety of Cevira® in patients with cervical histologic high-grade squamous intraepit... | |||||||||||||
Medical condition: Patients with cervical histologic HSIL. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) SK (Completed) PL (Completed) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002760-16 | Sponsor Protocol Number: 04/QO603/42 HEXVIX | Start Date*: 2005-01-12 | |||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: A randomised Study of “bluelight” hexyl amino levulinic acid (HAL) photodynamic assisted resection of bladder tumours versus conventional “white light” transurethral resection of newly diagnosed bl... | |||||||||||||
Medical condition: Superficial Bladder Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
